Jersey Bone Scan Recall Shows Why Diagnostic Quality Matters
Health and Care Jersey recalled around 250 people for repeat bone-density scans after an independent review found reporting concerns.
Health
Showing 61-72 of 206 articles
England's Doctor Deal Replaced the Withdrawn Training Offer
Resident doctors accepted a June deal promising at least 4,000 specialty training posts after an earlier 1,000-post package was withdrawn.
US Patented-Drug Tariffs Start With Multiple Rates
A US proclamation set a 100% ceiling for some patented-drug imports, while country deals, company agreements and product exemptions create lower or zero rates.
CDC Testing Pause Turned Rare-Disease Capacity Into the Story
The CDC's temporary pause on dozens of diagnostic tests, including rabies and mpox-related work, exposed how fragile rare-disease laboratory capacity becomes when staffing and replacement paths are unclear.
Training-Post Warning Deepened England Doctor Talks
The BMA said a warning over 1,000 specialty training posts inflamed April talks, while the government cited strike preparations and recruitment deadlines.
AI Chatbot Mental-Health Risks Need Stronger Evidence
Experiments and selected chat logs show serious chatbot failures, but anecdotes and small samples cannot establish prevalence or causation.
Wegovy Subscription Push Turns Obesity Care Into a Pricing Test
Novo Nordisk's Wegovy subscription plan gives self-pay patients lower monthly prices, but it also exposes the limits of consumer-style access to obesity drugs.
Gut Bacteria May Give Kidney Disease a New Target, Not a Shortcut
A mouse study mapped a feedback loop between kidney damage, gut nitrate and a bacterial toxin precursor, but it did not test a treatment in people.
Resident Doctors' Strike Showed Why NHS Delay Is a Workforce Problem
The April resident doctors' strike disrupted NHS care, but the later pay offer showed the deeper issue was retention, training posts and exhausted capacity.
NHS Wegovy Expansion Will Be Won or Lost in Primary Care
NHS England's Wegovy heart-risk rollout could cover around 1.2 million eligible people, but NICE forecasts a phased start shaped by capacity and local delivery.
NHS Wegovy Expansion Recasts Weight Loss as Heart Prevention
NHS England's Wegovy expansion puts semaglutide into cardiovascular prevention, but access, monitoring and capacity will decide its real impact.
UC Davis TB Blood Test Shows Promise as a Triage Tool
A blinded 408-sample trial found uneven accuracy across forms of active TB. The two-hour blood assay remains a laboratory triage candidate, not a stand-alone diagnosis.